FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
press_releaseUnited States·U.S. Food and Drug Administration·Wire Summary
The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.
AI Business Impact
How does this affect your business?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.